(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of OTC mRNA] CTD PMID:31150632 (5-hydroxyindol-3-yl)acetic acid affects abundance ISO RGD:11039 6480464 OTC gene mutant form affects the abundance of Hydroxyindoleacetic Acid CTD PMID:3374991 (5-hydroxyindol-3-yl)acetic acid multiple interactions ISO RGD:11039 6480464 Sodium Benzoate affects the reaction [OTC gene mutant form affects the abundance of Hydroxyindoleacetic Acid] CTD PMID:3374991 1,2-dichloroethane decreases expression ISO RGD:11039 6480464 ethylene dichloride results in decreased expression of OTC mRNA CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:11039 6480464 1, 2-Dimethylhydrazine results in decreased expression of OTC mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of OTC mRNA CTD PMID:17522070 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of OTC mRNA CTD PMID:17108234 17beta-estradiol multiple interactions EXP 6480464 Estradiol promotes the reaction [PRL protein results in increased activity of OTC protein] CTD PMID:3097147 17beta-estradiol decreases expression ISO RGD:732939 6480464 Estradiol results in decreased expression of OTC mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:11039 6480464 Tetrachlorodibenzodioxin results in decreased expression of OTC mRNA CTD PMID:16960034 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:11039 6480464 Tetrachlorodibenzodioxin affects the expression of OTC mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732939 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of OTC mRNA CTD PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of OTC mRNA CTD PMID:16960034 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of OTC mRNA CTD PMID:22298810 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of OTC mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of OTC mRNA CTD PMID:21346803 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:20959002 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin analog results in increased expression of OTC protein, alpha-Chlorohydrin results in increased expression of OTC protein CTD PMID:26597043 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of OTC mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of OTC mRNA CTD PMID:19483382 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of OTC mRNA CTD PMID:31881176 acetylsalicylic acid decreases expression ISO RGD:732939 6480464 Aspirin results in decreased expression of OTC protein CTD PMID:8295421 aflatoxin B1 decreases expression ISO RGD:11039 6480464 Aflatoxin B1 results in decreased expression of OTC mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:732939 6480464 Aflatoxin B1 results in decreased methylation of OTC gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:732939 6480464 Aflatoxin B1 results in decreased expression of OTC mRNA CTD PMID:22100608 , PMID:27153756 aflatoxin B1 affects expression ISO RGD:732939 6480464 Aflatoxin B1 affects the expression of OTC protein CTD PMID:20106945 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of OTC mRNA CTD PMID:19483382 ammonia affects metabolic processing ISO RGD:11039 6480464 OTC protein affects the metabolism of Ammonia CTD PMID:16677864 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of OTC mRNA CTD PMID:16483693 arsenic acid increases reduction EXP 6480464 OTC protein results in increased reduction of arsenic acid CTD PMID:19248796 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of OTC mRNA CTD PMID:19483382 benzo[a]pyrene decreases expression ISO RGD:11039 6480464 Benzo(a)pyrene results in decreased expression of OTC mRNA CTD PMID:19770486 benzo[a]pyrene decreases methylation ISO RGD:732939 6480464 Benzo(a)pyrene results in decreased methylation of OTC exon CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:732939 6480464 Benzo(a)pyrene affects the methylation of OTC 3' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:732939 6480464 Benzo(a)pyrene results in decreased expression of OTC mRNA CTD PMID:21871943 , PMID:32234424 benzo[b]fluoranthene decreases expression ISO RGD:11039 6480464 benzo(b)fluoranthene results in decreased expression of OTC mRNA CTD PMID:26377693 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of OTC mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:11039 6480464 bisphenol A results in increased expression of OTC mRNA CTD PMID:30245210 , PMID:33221593 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of OTC mRNA CTD PMID:30816183 , PMID:32528016 Calcimycin multiple interactions EXP 6480464 [Calcimycin co-treated with Cyclosporine] results in decreased activity of OTC protein more ... CTD PMID:3097147 carbon nanotube decreases expression ISO RGD:11039 6480464 Nanotubes more ... CTD PMID:25620056 chloroform decreases expression EXP 6480464 Chloroform results in decreased expression of OTC mRNA CTD PMID:17522070 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of OTC mRNA CTD PMID:19483382 cyclosporin A decreases expression ISO RGD:11039 6480464 Cyclosporine results in decreased expression of OTC mRNA CTD PMID:19770486 more ... cyclosporin A decreases expression ISO RGD:732939 6480464 Cyclosporine results in decreased expression of OTC mRNA CTD PMID:20106945 , PMID:23830897 cyclosporin A multiple interactions EXP 6480464 [Calcimycin co-treated with Cyclosporine] results in decreased activity of OTC protein more ... CTD PMID:3097147 cyclosporin A increases expression ISO RGD:11039 6480464 Cyclosporine results in increased expression of OTC protein CTD PMID:23308384 , PMID:25047351 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of OTC mRNA CTD PMID:17522070 diazinon decreases expression EXP 6480464 Diazinon results in decreased expression of OTC protein CTD PMID:26721910 dicrotophos decreases expression ISO RGD:732939 6480464 dicrotophos results in decreased expression of OTC mRNA CTD PMID:28302478 dioxygen decreases metabolic processing ISO RGD:732939 6480464 Oxygen results in decreased metabolism of OTC protein CTD PMID:11161710 dioxygen multiple interactions ISO RGD:732939 6480464 lactacystin inhibits the reaction [Oxygen results in decreased metabolism of OTC protein] CTD PMID:11161710 endosulfan multiple interactions ISO RGD:732939 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of OTC mRNA CTD PMID:26159488 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of OTC mRNA CTD PMID:29391264 erythromycin estolate decreases expression EXP 6480464 Erythromycin Estolate results in decreased expression of OTC mRNA CTD PMID:17522070 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of OTC mRNA CTD PMID:24136188 furan affects binding EXP 6480464 furan binds to OTC protein CTD PMID:22240984 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of OTC mRNA CTD PMID:24136188 glycine affects metabolic processing ISO RGD:11039 6480464 OTC gene mutant form affects the metabolism of Glycine CTD PMID:3091026 glycine multiple interactions ISO RGD:11039 6480464 Sodium Benzoate affects the reaction [OTC gene mutant form affects the metabolism of Glycine] CTD PMID:3091026 gossypol multiple interactions EXP 6480464 Gossypol inhibits the reaction [PRL protein results in increased activity of OTC protein], Gossypol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of OTC protein] CTD PMID:3097147 indometacin multiple interactions EXP 6480464 Indomethacin promotes the reaction [PRL protein results in increased activity of OTC protein] CTD PMID:3097147 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of OTC mRNA CTD PMID:19483382 lactacystin multiple interactions ISO RGD:732939 6480464 lactacystin inhibits the reaction [Oxygen results in decreased metabolism of OTC protein] CTD PMID:11161710 lactacystin decreases metabolic processing ISO RGD:732939 6480464 lactacystin results in decreased metabolism of OTC protein CTD PMID:11161710 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of OTC mRNA CTD PMID:11578147 lead diacetate increases expression ISO RGD:11039 6480464 lead acetate results in increased expression of OTC mRNA CTD PMID:22609695 masoprocol multiple interactions EXP 6480464 Masoprocol promotes the reaction [PRL protein results in increased activity of OTC protein] CTD PMID:3097147 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of OTC protein CTD PMID:30467583 N-nitrosodiethylamine multiple interactions EXP 6480464 [Phenobarbital co-treated with Diethylnitrosamine] results in decreased expression of OTC protein CTD PMID:20935162 N-nitrosomorpholine decreases expression EXP 6480464 N-nitrosomorpholine results in decreased expression of OTC protein CTD PMID:19716841 N-Nitrosopyrrolidine decreases expression ISO RGD:732939 6480464 N-Nitrosopyrrolidine results in decreased expression of OTC mRNA CTD PMID:32234424 naloxone decreases expression EXP 6480464 Naloxone results in decreased expression of OTC mRNA CTD PMID:17522070 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of OTC mRNA CTD PMID:24136188 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of OTC mRNA CTD PMID:24136188 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of OTC mRNA CTD PMID:33484710 O-methyleugenol decreases expression ISO RGD:732939 6480464 methyleugenol results in decreased expression of OTC mRNA CTD PMID:32234424 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of OTC mRNA CTD PMID:19483382 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of OTC protein CTD PMID:16687475 paracetamol decreases expression ISO RGD:732939 6480464 Acetaminophen results in decreased expression of OTC mRNA CTD PMID:29067470 paracetamol multiple interactions ISO RGD:11039 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in decreased expression of OTC mRNA] CTD PMID:29246445 paracetamol decreases expression ISO RGD:11039 6480464 Acetaminophen results in decreased expression of OTC mRNA CTD PMID:29246445 paracetamol increases expression ISO RGD:11039 6480464 Acetaminophen results in increased expression of OTC protein CTD PMID:11752693 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of OTC mRNA CTD PMID:17522070 , PMID:8878780 paracetamol affects expression ISO RGD:11039 6480464 Acetaminophen affects the expression of OTC mRNA CTD PMID:17562736 paraquat decreases import ISO RGD:732939 6480464 Paraquat results in decreased import of OTC protein CTD PMID:11161710 paraquat decreases metabolic processing ISO RGD:732939 6480464 Paraquat results in decreased metabolism of OTC protein CTD PMID:11161710 perfluorononanoic acid decreases expression ISO RGD:732939 6480464 perfluoro-n-nonanoic acid results in decreased expression of OTC mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of OTC mRNA CTD PMID:21723365 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:732939 6480464 perfluorooctane sulfonic acid results in decreased expression of OTC mRNA CTD PMID:32588087 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of OTC mRNA, perfluorooctanoic acid results in decreased expression of OTC protein CTD PMID:19162173 more ... perfluorooctanoic acid decreases expression ISO RGD:732939 6480464 perfluorooctanoic acid results in decreased expression of OTC mRNA CTD PMID:32588087 phenobarbital multiple interactions ISO RGD:11039 6480464 NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of OTC mRNA] CTD PMID:19482888 phenobarbital affects expression ISO RGD:732939 6480464 Phenobarbital affects the expression of OTC mRNA CTD PMID:19159669 phenobarbital decreases expression ISO RGD:11039 6480464 Phenobarbital results in decreased expression of OTC mRNA CTD PMID:19482888 phenobarbital multiple interactions EXP 6480464 [Phenobarbital co-treated with Diethylnitrosamine] results in decreased expression of OTC protein CTD PMID:20935162 phorbol 13-acetate 12-myristate increases activity EXP 6480464 Tetradecanoylphorbol Acetate results in increased activity of OTC protein CTD PMID:3097147 phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 [Calcimycin co-treated with Tetradecanoylphorbol Acetate] promotes the reaction [PRL protein results in increased activity of OTC protein] more ... CTD PMID:3097147 pirinixic acid multiple interactions ISO RGD:11039 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of OTC mRNA, PPARA protein promotes the reaction [pirinixic acid results in decreased expression of OTC mRNA] CTD PMID:20059764 , PMID:20813756 pirinixic acid decreases expression ISO RGD:11039 6480464 pirinixic acid results in decreased expression of OTC mRNA, pirinixic acid results in decreased expression of OTC protein CTD PMID:16807375 more ... pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of OTC mRNA CTD PMID:19483382 pirinixic acid multiple interactions ISO RGD:732939 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of OTC mRNA CTD PMID:19710929 Propiverine affects binding EXP 6480464 propiverine binds to OTC protein CTD PMID:29273565 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [PRL protein results in increased activity of OTC protein], Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of OTC protein] CTD PMID:3097147 quinacrine multiple interactions EXP 6480464 Quinacrine inhibits the reaction [PRL protein results in increased activity of OTC protein], Quinacrine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of OTC protein] CTD PMID:3097147 quinidine decreases expression EXP 6480464 Quinidine results in decreased expression of OTC mRNA CTD PMID:17522070 rac-1,2-dichloropropane increases activity EXP 6480464 propylene dichloride results in increased activity of OTC protein CTD PMID:2744274 serotonin affects metabolic processing ISO RGD:11039 6480464 OTC gene mutant form affects the metabolism of Serotonin CTD PMID:3374991 serotonin multiple interactions ISO RGD:11039 6480464 Sodium Benzoate affects the reaction [OTC gene mutant form affects the metabolism of Serotonin] CTD PMID:3374991 sodium arsenite decreases expression ISO RGD:732939 6480464 sodium arsenite results in decreased expression of OTC mRNA CTD PMID:29301061 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of OTC protein CTD PMID:29459688 sodium benzoate multiple interactions ISO RGD:11039 6480464 Sodium Benzoate affects the reaction [OTC gene mutant form affects the abundance of Hydroxyindoleacetic Acid] more ... CTD PMID:3091026 , PMID:3374991 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of OTC mRNA CTD PMID:25993096 tauroursodeoxycholic acid decreases expression EXP 6480464 ursodoxicoltaurine results in decreased expression of OTC mRNA CTD PMID:15885361 Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of OTC mRNA CTD PMID:21515302 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of OTC mRNA CTD PMID:17522070 , PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of OTC mRNA] CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:11039 6480464 Carbon Tetrachloride results in decreased expression of OTC mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of OTC mRNA CTD PMID:15963342 tetracycline decreases expression EXP 6480464 Tetracycline results in decreased expression of OTC mRNA CTD PMID:17522070 tetracycline decreases expression ISO RGD:11039 6480464 Tetracycline results in decreased expression of OTC mRNA CTD PMID:24489787 theophylline decreases expression EXP 6480464 Theophylline results in decreased expression of OTC mRNA CTD PMID:17522070 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of OTC mRNA CTD PMID:19483382 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of OTC mRNA CTD PMID:34492290 troglitazone increases expression ISO RGD:11039 6480464 troglitazone results in increased expression of OTC protein CTD PMID:18495193 troglitazone decreases expression ISO RGD:732939 6480464 troglitazone results in decreased expression of OTC mRNA CTD PMID:25572481 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of OTC protein CTD PMID:21315101 ursodeoxycholic acid decreases expression EXP 6480464 Ursodeoxycholic Acid results in decreased expression of OTC mRNA CTD PMID:15885361 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of OTC mRNA CTD PMID:24136188 valproic acid affects response to substance ISO RGD:732939 6480464 OTC affects the susceptibility to Valproic Acid CTD PMID:10227223 , PMID:9598692 valproic acid decreases expression ISO RGD:732939 6480464 Valproic Acid results in decreased expression of OTC mRNA CTD PMID:29154799